Home / GCNT3 Knockout Cell Lines

GCNT3 Knockout Cell Lines

Gene: GCNT3

Official Full Name: glucosaminyl (N-acetyl) transferase 3, mucin typeprovided by HGNC

Gene Summary: This gene encodes a member of the N-acetylglucosaminyltransferase family. The encoded protein is a beta-6-N-acetylglucosamine-transferase that catalyzes the formation of core 2 and core 4 O-glycans on mucin-type glycoproteins.[provided by RefSeq, Apr 2009]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO33408 GCNT3 Knockout cell line (HCT 116) Human GCNT3 1:2~1:4 Negative Online Inquiry
KO33409 GCNT3 Knockout cell line (A549) Human GCNT3 1:3~1:4 Negative Online Inquiry

Background

GCNT3 Gene Knockout Cell Lines represent a sophisticated tool for gene function studies, enabling researchers to investigate the biological roles of the GCNT3 gene with precision. These cell lines are genetically modified to lack the GCNT3 gene, facilitating studies on glycosylation pathways and their impacts on cellular behavior. The loss of GCNT3, an enzyme involved in the synthesis of specific complex carbohydrates, allows researchers to explore alterations in glycan structures, ultimately shedding light on processes such as cell signaling, adhesion, and immune responses.

The mechanisms through which these knockout cell lines function revolve around the absence of the GCNT3 protein, which directly affects glycobiology. By employing CRISPR-Cas9 or similar gene editing technologies, these cell lines ensure a reliable and reproducible model to study the ramifications of disrupted glycan structures in various biological contexts. This feature is invaluable for research into conditions such as cancer, autoimmune disorders, and infectious diseases, where glycosylation plays a significant role.

The scientific importance of GCNT3 Gene Knockout Cell Lines extends to both fundamental research and clinical applications. In the research environment, they facilitate the elucidation of the cellular and physiological consequences of altered glycosylation patterns. Clinically, these cell lines could lead to novel therapeutic targets and personalized medicine approaches, highlighting their relevance in the biotechnology and pharmaceutical landscapes.

One significant advantage of GCNT3 Gene Knockout Cell Lines over conventional models is their specificity and precision in targeting the GCNT3 gene, reducing off-target effects often associated with other genetic manipulation techniques. This specificity not only enhances the reliability of experimental outcomes but also supports downstream applications, such as drug screening and biomarker discovery.

For researchers and clinicians, having access to GCNT3 Gene Knockout Cell Lines means the ability to dissect complex biological questions with confidence. These cell lines represent a critical step forward in glycoscience, bolstering our understanding of cellular mechanisms and paving the way for innovative solutions in medical research.

Our company prides itself on delivering high-quality biological products backed by extensive research and developmental expertise, ensuring that our customers can rely on the scientific rigor and applicability of our offerings.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.